Ronald P Taylor

This inventor holds 15 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: University of Virginia Patent Foundation, Genmab Holding B.v., The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 1995-2025.

USPTO Granted Patents = 15 (Patent Applications = 5)

% Patents Active = 66.7

EPO Patents = 1

Average Co-Inventor Count = 5.8

ph-index = 6

Forward Citations = 317(Granted Patents)

Location History:

Charlottesville, VA (US) (1995 - 2010)
Keswick, VA (US) (2018 - 2022)

Company Filing History:

11 out of 1,040

University of Virginia Patent Foundation

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

4. 2 out of 2,651

University of Pennsylvania

patents

where one patent can have more than one assignee

Years Active: 1995-2025

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12275797 - Anti-CD37 antibodies and anti-CD20 antibodies, compositions and methods of use thereof (2025-04-14),

2. 11512137 - Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof (2022-11-29),

3. 11396553 - Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof (2022-07-26),

4. 11384139 - Antibody targeting cell surface deposited complement protein C3d and use thereof (2022-07-12),

5. 11034772 - Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof (2021-06-15),

6. 10035848 - Antibody targeting cell surface deposited complement protein C3d and use thereof (2018-07-31),

7. 7858087 - Enhancing the efficacy of immunotherapies by supplementing with complement (2010-12-28),

8. 7837997 - Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots (2010-11-23),

9. 7378094 - Therapeutic uses of complement receptor 2 (2008-05-27),

10. 7255858 - Enhancing the efficacy of immunotherapies by supplementing with complement (2007-08-14),

11. 7172760 - Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots (2007-02-06),

12. 6572856 - Methods for the prevention and treatment of cancer using anti-C3b(i) antibodies (2003-06-03),

13. 5879679 - Antigen-based heteropolymers and method for treating autoimmune diseases (1999-03-09),

14. 5487890 - Mammalian primate erythrocyte bound heteropolymerized monoclonal (1996-01-30),

15. 5470570 - Mammalian primate erythrocyte bound heteropolymerized monoclonal (1995-11-28),

Title: Inventor Ronald P Taylor - Revolutionizing Technology

Introduction: Ronald P Taylor, a distinguished inventor based in Charlottesville, VA, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Ronald P Taylor holds several patents in cutting-edge technologies related to artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach.

Career Highlights: With over two decades of experience in the industry, Ronald P Taylor has led numerous research projects that have resulted in game-changing inventions, earning him recognition as a pioneer in his field.

Collaborations: Throughout his career, Ronald P Taylor has collaborated with leading research institutions, universities, and tech companies to further develop and implement his innovative ideas, fostering a culture of creativity and progress.

Conclusion: In conclusion, Ronald P Taylor's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of technology, with his inventions poised to shape the future of various industries.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to [email protected]